Furthermore, ampelopsin suppressed the expression of leukemia stemness markers, including Oct4, Sox2, CD44, and CD133, in both cell lines, suggesting that ampelopsin exerts its chemotherapeutic effects by regulating both apoptosis and stemness of leukemia cells. Here, PROM1 is linked to leukemia.